MX2023012862A - Composicion topica de agentes esclerosantes en portadores acuosos. - Google Patents
Composicion topica de agentes esclerosantes en portadores acuosos.Info
- Publication number
- MX2023012862A MX2023012862A MX2023012862A MX2023012862A MX2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A MX 2023012862 A MX2023012862 A MX 2023012862A
- Authority
- MX
- Mexico
- Prior art keywords
- ulcers
- topical composition
- sclerosing
- sclerosing agents
- aqueous carriers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención, se refiere a una composición tópica con agentes esclerosantes compuesta de un agente esclerosante químico, un agente esclerosante osmótico y Cloruro de Metilrosanilina en un portador acuoso; con propiedades antimicóticas y antimicrobianas, así como un proceso para preparar dicha invención. Además, de su uso en el tratamiento de lesiones provocadas en la hipodermis, epidermis y dermis. Como son las lesiones contusas, incisas, punzantes, quemaduras de primero, segundo y tercer grado, úlceras de grado 1, 2 y 3, úlceras varicosas, úlcera por artritis, úlceras por presión, úlceras de pie diabético, así como en cualquier ecosistema cutáneo.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2023012862A MX2023012862A (es) | 2023-10-27 | 2023-10-27 | Composicion topica de agentes esclerosantes en portadores acuosos. |
| PCT/MX2024/050053 WO2025089937A1 (es) | 2023-10-27 | 2024-10-02 | Composición tópica de agentes esclerosantes en portadores acuosos |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2023012862A MX2023012862A (es) | 2023-10-27 | 2023-10-27 | Composicion topica de agentes esclerosantes en portadores acuosos. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023012862A true MX2023012862A (es) | 2023-11-09 |
Family
ID=91375431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023012862A MX2023012862A (es) | 2023-10-27 | 2023-10-27 | Composicion topica de agentes esclerosantes en portadores acuosos. |
Country Status (2)
| Country | Link |
|---|---|
| MX (1) | MX2023012862A (es) |
| WO (1) | WO2025089937A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3224940A (en) * | 1961-12-18 | 1965-12-21 | Lilly Co Eli | Antacid compositions and method of using same |
| CA1024048A (en) * | 1973-10-29 | 1978-01-10 | Richard Sternheimer | Urinary sediment stain |
| CN1059322C (zh) * | 1995-05-05 | 2000-12-13 | 周波 | 高分子合成材料重睑术用聚丙烯的处理方法 |
| SE520670C2 (sv) * | 2001-12-18 | 2003-08-12 | Sca Hygiene Prod Ab | Andningsbart absorberande alster med konformade hålrum och metod för framställning |
| WO2014081715A1 (en) * | 2012-11-20 | 2014-05-30 | Vita Naturale, Llc | Compositions and methods for their dermatological use |
| EP2948154A4 (en) * | 2013-01-28 | 2016-09-14 | Urigen Pharmaceuticals Inc | STABLE COMPOSITIONS WITH HEPARINOID, A DIRECT ANESTHETIC, AND A BUFFER |
| US20160244955A1 (en) * | 2015-02-20 | 2016-08-25 | Phillip Morisson Allred, III | Delivery System for Cleaning & Maintaining Drains and Methods Associated Therewith |
| EP3501496A1 (en) * | 2017-12-22 | 2019-06-26 | Cosmo Technologies Ltd. | Liquid delivery composition |
-
2023
- 2023-10-27 MX MX2023012862A patent/MX2023012862A/es unknown
-
2024
- 2024-10-02 WO PCT/MX2024/050053 patent/WO2025089937A1/es active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025089937A1 (es) | 2025-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020010405A (es) | Composicion para el tratamiento de heridas cronicas. | |
| MX2023000316A (es) | Composiciones farmaceuticas y metodos para el tratamiento de la enfermedad de parkinson. | |
| ECSP20010477A (es) | Composición tópica semisólida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños crónicos de la piel | |
| MX2019008123A (es) | Articulo con estructura soluble de trama fibrosa que comprende agentes activos. | |
| BR112014009713A2 (pt) | administração transdérmica de agentes bioativos de alta viscosidade | |
| AR058821A1 (es) | Metodos, sistemas y composiciones de tratamiento graduables por el usuario para el tratamiento del acne | |
| MX338611B (es) | Una composicion farmaceutica sinergistica novedosa para aplicaciones topicas. | |
| CR10166A (es) | Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania | |
| EA202191212A1 (ru) | Композиции и способы для обработки биопленок без индуцирования резистентности к противомикробным препаратам | |
| MX385380B (es) | Formulacion topica para promover la curacion de heridas. | |
| MX2024005303A (es) | Formulaciones biotensioactivas para su uso en el cuidado de la piel y el tratamiento de heridas. | |
| PE20212158A1 (es) | Composicion farmaceutica acuosa de anticuerpo anti-il17a y su uso | |
| CL2021000509A1 (es) | Composiciones farmacéuticas semisólidas de base oleosa conteniendo pirfenidona para su aplicación en la reparación tisular | |
| MX2023012862A (es) | Composicion topica de agentes esclerosantes en portadores acuosos. | |
| CU24390B1 (es) | Piperidinil-tetrahidroquinolinas sustituidas | |
| AR117730A1 (es) | Composición para relajación muscular | |
| MX2020005056A (es) | Emulsiones para el tratamiento tópico de infecciones dérmicas y de mucosas. | |
| CR20160277A (es) | Piperidinil tetrahidroquinolinas sustituidas | |
| BR112014007210A2 (pt) | emplastro com oclusão reajustável | |
| CL2020002509A1 (es) | Entrega topica y transdermica de un quelante de hierro para prevenir y tratar heridas cronicas. | |
| MX2022010960A (es) | Métodos y composiciones para tratar el trastorno por uso de cannabis y mitigar la abstinencia de cannabinoides. | |
| PE20140589A1 (es) | Proteina antimicrobiana | |
| MX2015015379A (es) | Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos. | |
| AR114314A1 (es) | Carbonato de calcio tratado mediante reacción superficial para modificar las propiedades biomecánicas de la piel | |
| MX2022010093A (es) | Tafoxiparina para el tratamiento de la preeclampsia. |